“Made in Canada”: The challenges of increasing domestic production of pharmaceuticals The pandemic caused by COVID 19 and the subsequent slowdown in international trade have highlighted certain challenges faced by a globally integrated supply chain, such as shortages of personal protec...

“move away from #centralizedproduction in one country could bring significant opportunities to Canada
…some investors may prefer to finance new plants in a country such as #Canada
…the challenge would be to ensure that Canada has… #specialized #workforce & #materials to ensure a #swifttransition…”